V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10386123 | 10056817 | 1.8 | null | null | 2017-10-15 | 2017-11-26 | PERTUZUMAB + TRASTUZUMAB | null | null | VINORELBINE | 101063711 |
| 10386166 | 10056818 | 1.85 | 76.9 | null | 2019-09-19 | 2019-09-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | BORTEZOMIB + THALIDOMIDE | 101572943 |
| 10386170 | 10056819 | 1.7 | null | Palliative (P) | 2018-12-12 | 2019-01-14 | Melphalan IV High dose | 02 | N | MELPHALAN | 100554719 |
| 10386259 | 10056820 | 1.8 | 76.9 | null | 2019-12-24 | 2019-12-24 | Cyclophosphamide oral | null | null | CYCLOPHOSPHAMIDE | 100045841 |
| 10386265 | 10056821 | 1.81 | 77.4 | Palliative (P) | 2019-11-25 | 2020-01-20 | DABRAFENIB + TRAMETINIB | 02 | N | NIRAPARIB | 101452827 |
| 10386424 | 10056822 | 1.68 | 63 | null | 2016-08-16 | 2016-09-11 | null | 02 | null | DABRAFENIB | 100487604 |
| 10386551 | 10056825 | 1.81 | 66 | null | 2019-08-05 | 2019-08-19 | Cabazitaxel | 02 | null | CABAZITAXEL | 101836504 |
| 10386670 | 10056826 | 1.68 | 73 | null | 2019-05-03 | 2019-05-03 | Vinorelbine (oral) | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101070837 |
| 10386908 | 10056828 | 1.7 | 71.4 | null | 2019-12-19 | 2020-01-01 | CISPLATIN + VINORELBINE + RT | 02 | null | CAPECITABINE + IRINOTECAN | 101486737 |
| 10387021 | 10056829 | 1.66 | 86.7 | null | 2018-02-01 | 2018-04-23 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | null | CYCLOPHOSPHAMIDE | 100778654 |
| 10387172 | 10056830 | 1.78 | 74.6 | null | 2018-05-18 | 2018-11-17 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101149574 |
| 10387213 | 10056831 | 1.62 | 101.2 | 03 | 2020-01-29 | 2020-02-09 | GEMCITABINE | 02 | N | GEMCITABINE | 100444504 |
| 10387287 | 10056832 | 1.55 | 59.2 | Disease modification (D) | 2019-10-04 | 2019-10-09 | BUSULFAN | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100832387 |
| 10387455 | 10056835 | 1.73 | 76.9 | null | 2020-07-05 | 2020-07-24 | Palbociclib | 99 | null | PALBOCICLIB | 100642170 |
| 10387611 | 10056837 | 1.69 | 78 | Curative (C) | 2018-03-06 | 2018-03-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | DABRAFENIB | 100167365 |
| 10387807 | 10056839 | 1.59 | 57.5 | null | 2018-03-22 | 2019-02-06 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100494608 |
| 10387850 | 10056840 | 1.7 | 47.2 | Palliative (P) | 2021-12-04 | 2022-03-05 | Azacitidine | 02 | N | AZACITIDINE | 100801955 |
| 10387965 | 10056841 | 1.69 | null | Curative (C) | 2017-09-04 | 2017-10-02 | Melphalan IV High dose | 02 | N | MELPHALAN | 101679067 |
| 10388018 | 10056842 | 1.91 | null | Palliative (P) | 2018-10-02 | 2019-01-21 | Melphalan IV High dose | 02 | N | MELPHALAN | 101054566 |
| 10388184 | 10056843 | 1.65 | null | null | null | 2020-04-26 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100641963 |
| 10388212 | 10056845 | 1.72 | 92.5 | 03 | 2020-11-18 | 2020-11-26 | null | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100539760 |
| 10388255 | 10056846 | 1.67 | 92 | null | 2012-03-15 | 2022-03-24 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 100073944 |
| 10388297 | 10056847 | 1.66 | 69.9 | Palliative (P) | 2020-02-06 | 2020-02-07 | DABRAFENIB + TRAMETINIB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101333234 |
| 10388341 | 10056848 | 1.91 | 74.4 | null | 2020-05-21 | 2020-06-02 | GEMCITABINE | 02 | null | GEMCITABINE | 100120971 |
| 10388411 | 10056849 | 1.57 | 93.7 | null | 2019-01-28 | 2019-06-29 | PERTUZUMAB + TRASTUZUMAB | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100296978 |
| 10388440 | 10056850 | 1.81 | 0 | null | 2019-10-10 | 2020-07-17 | Niraparib | 02 | null | IPILIMUMAB + NIVOLUMAB | 101539323 |
| 10388489 | 10056851 | 1.55 | 40.4 | null | 2015-10-08 | 2017-03-02 | PERTUZUMAB + TRASTUZUMAB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100070013 |
| 10388525 | 10056852 | 1.63 | 71.9 | Palliative (P) | 2019-08-30 | 2019-09-13 | CABOZANTINIB | 02 | N | NIRAPARIB | 101203313 |
| 10388541 | 10056853 | 1.75 | 66.6 | Curative (C) | 2017-05-20 | 2020-01-20 | AFATINIB | 02 | N | AFATINIB | 101400304 |
| 10388558 | 10056854 | 0 | 63 | Palliative (P) | 2019-05-04 | 2019-05-04 | Azacitidine | 02 | N | AZACITIDINE | 100157464 |
| 10388605 | 10056855 | 1.54 | 62.6 | Palliative (P) | 2019-10-17 | 2019-10-17 | Azacitidine | null | N | AZACITIDINE | 101429263 |
| 10388815 | 10056857 | 1.72 | 60.3 | null | 2017-11-24 | 2017-11-25 | Melphalan IV High dose | N | null | MELPHALAN | 101530889 |
| 10388834 | 10056859 | 1.78 | 50.5 | null | 2017-08-04 | 2017-08-15 | AFATINIB | 02 | null | AFATINIB | 101773311 |
| 10389303 | 10056860 | 1.77 | null | Palliative (P) | 2019-02-01 | 2019-02-02 | Cyclophosphamide Weekly IV | 02 | N | CYCLOPHOSPHAMIDE | 101789811 |
| 10389602 | 10056863 | 1.62 | 83.6 | Adjuvant (A) | 2019-04-29 | 2019-04-29 | PERTUZUMAB + TRASTUZUMAB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100083982 |
| 10389680 | 10056864 | 1.75 | 71 | null | 2019-08-22 | 2019-08-24 | Cyclophosphamide Weekly PO | 02 | null | CYCLOPHOSPHAMIDE | 101663957 |
| 10389797 | 10056866 | 1.56 | 66.5 | Palliative (P) | 2018-06-01 | 2019-08-01 | DABRAFENIB | 01 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100984617 |
| 10390065 | 10056868 | 1.52 | 84.1 | null | 2019-02-14 | 2019-02-20 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101295404 |
| 10390163 | 10056869 | 1.55 | 69.7 | Palliative (P) | 2018-10-08 | 2018-10-12 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100682907 |
| 10390166 | 10056870 | 1.74 | 53.2 | null | 2020-06-01 | 2020-06-01 | Carboplatin + Liposomal Doxorubicin | 99 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100576185 |
| 10390535 | 10056873 | 1.69 | 57.8 | Neo-adjuvant (N) | null | 2020-09-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100994518 |
| 10390565 | 10056875 | 1.7 | 83.4 | Palliative (P) | 2018-01-19 | 2018-01-26 | Cetuximab 14 day | 02 | N | DABRAFENIB | 100055524 |
| 10390590 | 10056876 | 1.81 | 55.1 | null | 2017-10-18 | 2017-10-26 | PERTUZUMAB + TRASTUZUMAB | 02 | null | CAPECITABINE + IRINOTECAN | 100075916 |
| 10390613 | 10056877 | 1.8 | 91.2 | Palliative (P) | 2018-01-01 | 2018-01-01 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101441547 |
| 10390634 | 10056878 | 1.6 | 89 | 03 | 2022-04-26 | 2022-05-03 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100489575 |
| 10390747 | 10056879 | 1.54 | 69 | null | 2018-11-09 | 2018-12-07 | Azacitidine | N | null | AZACITIDINE | 101002853 |
| 10391100 | 10056881 | 1.48 | 60.3 | null | 2017-01-08 | 2018-02-20 | GEMCITABINE | 02 | null | GEMCITABINE | 100990484 |
| 10391149 | 10056882 | 0 | 64 | Adjuvant (A) | 2018-01-08 | 2018-01-13 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100594505 |
| 10391233 | 10056883 | 1.57 | 76 | Palliative (P) | 2019-08-13 | 2019-11-24 | Cisplatin + Vinorelbine (IV) | 02 | N | VINORELBINE | 101481083 |
| 10391458 | 10056887 | 1.75 | 68 | null | 2017-05-13 | 2018-06-28 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 101610445 |